Belmont, MA, United States of America

Dustan Bonnin

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 2.7

ph-index = 3

Forward Citations = 40(Granted Patents)


Company Filing History:


Years Active: 2010-2017

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations of Dustan Bonnin in Vaccine Development

Introduction

Dustan Bonnin is an accomplished inventor based in Belmont, MA (US), known for his significant contributions to the field of vaccine development. With a total of five patents to his name, Bonnin has focused on creating innovative methods for designing and preparing vaccines that utilize directed sequence polymer compositions.

Latest Patents

Bonnin's latest patents include groundbreaking inventions that enhance vaccine efficacy. One notable patent is titled "Methods for designing and preparing vaccines comprising directed sequence polymer compositions via the directed expansion of epitopes." This invention outlines a process for preparing a composition that includes directed sequence polymer (DSP) mixtures acting as epitopes, which are useful as vaccines. The DSP is synthesized based on specific rules regarding the identity and frequency of amino acids that substitute a base or native amino acid of a known epitope. The resulting composition consists of a mixture of related peptides intended for therapeutic use, particularly against immune evasive infectious agents.

Another significant patent is "Synthesis of directed sequence polymer compositions and antibodies thereof for the treatment of protein conformational disorders." This invention describes a solid-phase synthesis process for directed epitope peptide mixtures that are beneficial in treating and diagnosing protein conformational disorders. The process is defined by a set of rules regarding amino acid substitutions, leading to a composition of related peptides for therapeutic applications. Additionally, this invention includes the generation of antibodies using the directed epitope peptide mixtures as antigens, which are useful in the treatment and diagnostics of protein conformational disorders.

Career Highlights

Throughout his career, Bonnin has worked with notable companies in the pharmaceutical industry, including Declion Pharmaceuticals, Inc. and Peptimmune, Inc. His work has significantly impacted the development of therapeutic solutions in the field of immunology.

Collaborations

Bonnin has collaborated with esteemed colleagues such as Eric Zanelli and James Rasmussen, contributing to the advancement of innovative solutions in vaccine technology.

Conclusion

Dustan Bonnin's innovative work in vaccine development showcases his dedication to improving therapeutic strategies against infectious diseases and protein conformational disorders. His patents reflect a commitment to advancing medical science through innovative approaches.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…